Add to ORKGpeer reviewedThromboembolic complications are well known side effects of treatment with tamoxifen in patients with breast cancer. The authors review the pathophysiology and the risk factors that increase the probability to develop these complications. The most appropriate treatment is discussed
Tamoxifen is an antagonist of the oestrogen receptor, used in the treatment of breast cancer. It is ...
Le cancer du sein reste la principale cause de décès par cancer chez les femmes et est connu pour la...
peer reviewedNumerous studies have examined the risk of breast cancer in patients with postmenopausa...
peer reviewedThromboembolic complications are well known side effects of treatment with tamoxifen in...
Ievads. Tamoksifēns ir krūts vēža terapijas medikaments. Tas ir selektīvs estrogēnu receptoru antago...
Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first li...
peer reviewedClinical and experimental studies indicate that combined unique conjugated estrogens an...
Il existe une relation étroite entre le cancer du sein et le poids. Si l’excès de poids est un facte...
Le cancer du sein touche principalement des femmes ménopausées avec une moyenne d’âge proche de 60 a...
Le cancer du sein est le cancer le plus fréquent chez la femme et malgré une baisse de la mortalité ...
O tamoxifeno (TAM) é o tratamento referência para o câncer de mama sensível ao estrogênio. O TAM é m...
Background and Objectives: The interplay between reproductive hormones and breast cancer is well est...
AbstractIntroductionTamoxifen reduces breast cancer risk, but can cause thromboembolic complications...
Estrogen is a driver for the development and progression of luminal breast cancer, and up to 80% of ...
La enfermedad tromboembólica venosa constituye una entidad clínica compleja y cuya aparición se encu...
Tamoxifen is an antagonist of the oestrogen receptor, used in the treatment of breast cancer. It is ...
Le cancer du sein reste la principale cause de décès par cancer chez les femmes et est connu pour la...
peer reviewedNumerous studies have examined the risk of breast cancer in patients with postmenopausa...
peer reviewedThromboembolic complications are well known side effects of treatment with tamoxifen in...
Ievads. Tamoksifēns ir krūts vēža terapijas medikaments. Tas ir selektīvs estrogēnu receptoru antago...
Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first li...
peer reviewedClinical and experimental studies indicate that combined unique conjugated estrogens an...
Il existe une relation étroite entre le cancer du sein et le poids. Si l’excès de poids est un facte...
Le cancer du sein touche principalement des femmes ménopausées avec une moyenne d’âge proche de 60 a...
Le cancer du sein est le cancer le plus fréquent chez la femme et malgré une baisse de la mortalité ...
O tamoxifeno (TAM) é o tratamento referência para o câncer de mama sensível ao estrogênio. O TAM é m...
Background and Objectives: The interplay between reproductive hormones and breast cancer is well est...
AbstractIntroductionTamoxifen reduces breast cancer risk, but can cause thromboembolic complications...
Estrogen is a driver for the development and progression of luminal breast cancer, and up to 80% of ...
La enfermedad tromboembólica venosa constituye una entidad clínica compleja y cuya aparición se encu...
Tamoxifen is an antagonist of the oestrogen receptor, used in the treatment of breast cancer. It is ...
Le cancer du sein reste la principale cause de décès par cancer chez les femmes et est connu pour la...
peer reviewedNumerous studies have examined the risk of breast cancer in patients with postmenopausa...